Re-craniotomy and Complications After Elective Neurosurgery
NCT ID: NCT03910556
Last Updated: 2019-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
439 participants
OBSERVATIONAL
2017-01-31
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Post-anesthesia Management in Patients Undergoing Neurosurgery
NCT04362709
Patterns and Outcomes of Neurosurgery in England Over a Five-year Period
NCT05097066
Postoperative Cognitive Dysfunction in Geriatric Patients
NCT00512200
eCRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome
NCT01987648
A Comparison of Pain Scales in Patients With Disorder of Consciousness Following Craniotomy
NCT01547663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intraoperative information contain anesthetic technique, total dosage of propofol, fentanyl, and other anesthetic agents, total blood loss, types and amount of fluid replacement, volume of blood transfusion, latest body temperature, and the ability of safe extubation.
Postoperative complications will be categorized in to general conditions, neurological complications, and systemic problems. General conditions such as on endotracheal tube overnight and postoperative blood transfusion. Neurological complications include worsen increased ICP, intracranial hematoma, seizures, newly-developed motor deficit, cranial nerve palsy, CSF rhinorrhea, and emergency re-craniotomy. Systemic problems are hypothermia, electrolyte imbalance, anemia, hypertension, and hyperglycemia. Postoperative nausea and vomiting and the rescued anti-emetic drugs will be recorded. Postoperative anti-epileptic drug (AED) and pain medication will be collected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no complication
the patients who did not develop any kind of complication and no re-craniotomy
Propofol
intraoperative factors
with complication (s)
the patients who developed at least one of non-neurological complication or required re-craniotomy
Propofol
intraoperative factors
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propofol
intraoperative factors
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are planned for general anesthesia
* Patients have read the study information and signed in the consent form
Exclusion Criteria
* Patients who are scheduled for minor surgical procedures such as ventriculostomy and VP-shunt
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yodying Punjasawadwong
UNKNOWN
Prangmalee Leucharussamee
UNKNOWN
Ananchanok Saringkarinkul
UNKNOWN
Patipan Krungsri
UNKNOWN
Chiang Mai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pathomporn Pin on, M.D.
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pathomporn Pin-on, MD
Role: PRINCIPAL_INVESTIGATOR
Chiang Mai University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANE-2561-05961
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.